我要投票 红花牌在生发行业中的票数:514
· 外 推 电 报 ·
2025-08-20 08:51:21 星期三

【红花牌是哪个国家的品牌?】

红花牌是什么牌子?「红花牌」是 天津宏仁堂药业有限公司 旗下著名品牌。该品牌发源于天津,由创始人张彦森在1980期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力红花牌品牌出海!将品牌入驻外推网,定制红花牌品牌推广信息,可以显著提高红花牌产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天津宏仁堂药业有限公司始建于1923年,是由乐家老铺(北京同仁堂)第13代传人乐笃周先生所创建。

公司产品以面散剂为传统、胶囊剂为特色涉及内、外、妇、儿、皮肤、五官等科室,注册商标为“红花牌”。产品覆盖到我国二十多个省市自治区,部分产品已打入国际市场。主要产品有脑灵素、血府逐瘀胶囊、养血生发胶囊、白癜风胶囊、冠心苏合胶囊、紫雪等56个中药精品。

如今的宏仁堂已正式更名为“天津宏仁堂药业有限公司”,并改制为以天津市医药集团有限公司、天津同仁堂集团股份有限公司为投资主体的多元化现代企业,注册商标“红花牌”,为驰名保护。

面对激烈的市场竞争和中药现代化步伐的加快,企业始终秉持“修合虽无人见,存心自有天知”的古训和药德思想,贯彻“为客户实现价值,为员工提供机会,为社会承担责任”的企业宗旨,以“矢志不渝、锐意创新、忠诚营销、共享繁荣”的经营理念,全面贯彻实施大品种战略。紧紧围绕拳头产品“血府逐瘀胶囊”,构建了以血府逐瘀胶囊、养血生发胶囊、冠心苏和胶囊、白癜风胶囊为支撑的大品种群,每年以两位数的年经济增长速度,带动企业向规模经济发展。

吃水不忘挖井人,如此成绩的取得自然离不开历代红花人辛勤的汗水和艰苦创业、拼搏进取的精神。回首企业90年的艰辛历程,从乐笃周先生满怀热情创建宏仁堂,到今天走在我国中医药产业中,享有举足轻重的地位的天津宏仁堂药业有限公司;从最初几十人前店后厂式的作坊,到目前拥有日益壮大的科技,营销,生产,检验等高水平,高素质的员工队伍及先进的全自动生产设备和检验仪器。人均利税创同行业最高水平的大中型企业,实现了跨越式发展。企业不仅成功研制胶囊剂型,成为该剂型的发源地,而且拓宽了研发药品的范围,将传统医学与现代技术完美结合,涉及内、外、妇、儿、皮肤、五官等各科,培育出54个中药精品。其中,红花牌“血府逐瘀胶囊”依靠过硬的质量及疗效,通过科学营销手段,产品在全国医患者中享有广泛影响力,已形成相当规模,被列入天津市医药集团重点发展品种。1994年天津宏仁堂药业有限公司还被国家内贸部正式授予“中华老字号”荣誉称号。天津宏仁堂药业有限公司,站在赛达新园区,宏仁堂再次跨入了崭新的发展历程,为自己未来在新园区的全速起航描绘了新的画卷,为弘扬祖国医药文化再创辉煌!

英文翻译:Tianjin hongrentang Pharmaceutical Co., Ltd. was founded in 1923 by Mr. Le Duzhou, the 13th generation successor of lejialaopu (Beijing Tongrentang). The company's products are characterized by traditional powder and capsule, involving internal, external, women, children, skin, facial features and other departments, with the registered trademark of "Honghua brand". The products cover more than 20 provinces and autonomous regions in China, and some of them have entered the international market. The main products are Naolingsu, Xuefu Zhuyu Capsule, Yangxue Shengfa capsule, vitiligo capsule, Guanxinsuhe capsule, Zixue and other 56 excellent traditional Chinese medicine products. Now, hongrentang has officially changed its name to "Tianjin hongrentang Pharmaceutical Co., Ltd." and has been transformed into a diversified modern enterprise with Tianjin Pharmaceutical Group Co., Ltd. and Tianjin Tongrentang Group Co., Ltd. as the main investors, with the registered trademark of "honghuapai" for well-known protection. In the face of the fierce market competition and the acceleration of the modernization of traditional Chinese medicine, the enterprise always adheres to the ancient motto and medical ethics of "no one can see the repair, but the enterprise has a natural knowledge", implements the enterprise tenet of "realizing value for customers, providing opportunities for employees, and taking responsibility for the society", and comprehensively implements the business philosophy of "unswerving, determined innovation, loyal marketing, sharing and prosperity" Implement the strategy of large variety. Focusing on the key product "Xuefu Zhuyu Capsule", a large variety group supported by Xuefu Zhuyu Capsule, Yangxue Shengfa capsule, Guanxinsuhe capsule and vitiligo capsule has been established. With a double-digit annual economic growth rate every year, the company is driven to develop into a scale economy. Draught does not forget to dig wells, such achievements can not be achieved without the hard work of generations of Honghua people and the spirit of hard work, hard work and enterprising. Looking back on the 90 years of hard work of the enterprise, from Mr. leduzhou's enthusiastic creation of hongrentang to today's Tianjin hongrentang Pharmaceutical Co., Ltd., which plays an important role in China's traditional Chinese medicine industry; from the first dozens of factory style workshops in front of the store, to the present day, it has a growing number of high-level, high-quality staff and advanced technology, marketing, production, testing, etc Automatic production equipment and inspection instruments. The per capita profits and taxes have reached the highest level of large and medium-sized enterprises in the same industry, realizing leapfrog development. The enterprise has not only successfully developed the capsule dosage form and become the birthplace of the dosage form, but also broadened the scope of drug research and development, perfectly combined traditional medicine with modern technology, involving internal, external, women, children, skin, facial features and other branches, and cultivated 54 excellent traditional Chinese medicine products. Among them, Honghua brand "Xuefu Zhuyu Capsule" relies on excellent quality and curative effect, through scientific marketing means, the product enjoys wide influence in the national medical patients, has formed a considerable scale, and has been listed in the key development varieties of Tianjin Pharmaceutical Group. In 1994, Tianjin hongrentang Pharmaceutical Co., Ltd. was officially awarded the honorary title of "China time honored brand" by the Ministry of internal trade. Tianjin hongrentang Pharmaceutical Co., Ltd. is standing in Saida new park. Hongrentang has once again stepped into a new development process. It has described a new picture for its full speed sailing in the new park in the future, and created another brilliant future for promoting the pharmaceutical culture of the motherland!

本文链接: https://www.waitui.com/brand/f66b27803.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

啤酒企业探索“啤酒+饮品”战略布局

据统计,截至8月19日,A股7家啤酒上市公司中,重庆啤酒股份有限公司、北京燕京啤酒股份有限公司、福建省燕京惠泉啤酒股份有限公司均已披露了2025年半年度报告。另外,广州珠江啤酒股份有限公司、西藏发展股份有限公司、兰州黄河企业股份有限公司三家啤酒上市公司已发布半年度业绩预告。在上述啤酒上市公司发布的半年度业绩预告或半年报中,大多提及竞争加剧是行业面临的共同挑战。与此同时,探索多元化发展路径成为行业共识,构建“啤酒+饮品”版图成为部分公司战略发展的重心。(证券日报)

52分钟前

中金:具身机器人行业进入迅速发展阶段,建议关注国内线缆厂配套成长机遇

36氪获悉,中金研报称,近年来,具身机器人行业进入迅速发展阶段,宇树等头部主机厂实现小批量出货、开始意识到线缆的机械性能和使用寿命对于机器人本体的重要性;我们认为具身机器人线缆行业进入壁垒高、市场潜力足,有望随头部主机厂同步放量,建议关注国内线缆厂配套成长机遇。

52分钟前

乘股市回暖东风,含权类理财产品销售升温

在政策与市场的双轮驱动下,不少含权类理财产品近期表现亮眼。有银行客户经理表示,部分业绩表现良好的含权类理财产品出现了资金持续流入的情况。含权类理财产品销售热度升温的背后,离不开银行理财公司的大力布局。采访多家国有大行、股份行、城商行理财公司内部人士发现,加大布局含权类理财产品已成为行业共识。有银行理财公司人士表示,在“资产荒”背景下,含权类理财产品有望成为银行理财公司提升产品规模的重要发力点。(中证网)

52分钟前

华泰证券:重视稀土战略地位,看好价格上行

36氪获悉,华泰证券研报称,重视稀土战略地位,看好价格上行。预期2025—2026年稀土价格中枢有望持续上行。此外,在“逆全球化”背景下,稀土的战略意义愈发凸显。7月启动的金属镨钕竞拍表现活跃,市场看涨情绪浓烈。在稀土价格中枢有望上行的背景下,预期相关公司业绩将持续改善。

52分钟前

绩优产品限购 配置菜单更新,基金公司营销“画风”生变

近期市场行情火热,不少绩优基金却开启了“限购”模式。这既是避免基金规模快速扩张,从而摊薄现有基金持有人收益的需要,也是基金公司从规模导向向投资者回报导向转型的体现。梳理发现,近期限购的绩优基金多聚焦于创新药、科技、军工等今年以来的热门赛道,这些赛道交易普遍较为拥挤。与此同时,不少基金公司也在挖掘一些其他细分赛道的基金或是“固收+”、FOF等产品,为投资者均衡配置提供可选“菜单”。(中证网)

52分钟前

本页详细列出关于红花牌的品牌信息,含品牌所属公司介绍,红花牌所处行业的品牌地位及优势。
咨询